116 related articles for article (PubMed ID: 15569514)
1. [Copper treatment alters the barrier functions of human intestinal Caco-2 cells].
Liu ZW; Chen JL; Chen BH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):406-10. PubMed ID: 15569514
[TBL] [Abstract][Full Text] [Related]
2. Copper treatment alters the barrier functions of human intestinal Caco-2 cells: involving tight junctions and P-glycoprotein.
Liu Z; Chen B
Hum Exp Toxicol; 2004 Aug; 23(8):369-77. PubMed ID: 15346718
[TBL] [Abstract][Full Text] [Related]
3. Impact of copper oxide nanomaterials on differentiated and undifferentiated Caco-2 intestinal epithelial cells; assessment of cytotoxicity, barrier integrity, cytokine production and nanomaterial penetration.
Ude VC; Brown DM; Viale L; Kanase N; Stone V; Johnston HJ
Part Fibre Toxicol; 2017 Aug; 14(1):31. PubMed ID: 28835236
[TBL] [Abstract][Full Text] [Related]
4. High glucose concentration in isotonic media alters caco-2 cell permeability.
D'Souza VM; Shertzer HG; Menon AG; Pauletti GM
AAPS PharmSci; 2003; 5(3):E24. PubMed ID: 14621959
[TBL] [Abstract][Full Text] [Related]
5. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
[TBL] [Abstract][Full Text] [Related]
6. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.
Wang Y; Cao J; Wang X; Zeng S
Chirality; 2010 Mar; 22(3):361-8. PubMed ID: 19575464
[TBL] [Abstract][Full Text] [Related]
8. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
9. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
Ma L; Yang XW
Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
[TBL] [Abstract][Full Text] [Related]
10. Copper treatment alters the permeability of tight junctions in cultured human intestinal Caco-2 cells.
Ferruzza S; Scarino ML; Rotilio G; Ciriolo MR; Santaroni P; Muda AO; Sambuy Y
Am J Physiol; 1999 Dec; 277(6):G1138-48. PubMed ID: 10600810
[TBL] [Abstract][Full Text] [Related]
11. Sucrose esters increase drug penetration, but do not inhibit p-glycoprotein in caco-2 intestinal epithelial cells.
Kiss L; Hellinger É; Pilbat AM; Kittel Á; Török Z; Füredi A; Szakács G; Veszelka S; Sipos P; Ózsvári B; Puskás LG; Vastag M; Szabó-Révész P; Deli MA
J Pharm Sci; 2014 Oct; 103(10):3107-19. PubMed ID: 25042090
[TBL] [Abstract][Full Text] [Related]
12. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
13. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
14. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
15. Rhamnolipids enhance epithelial permeability in Caco-2 monolayers.
Jiang L; Long X; Meng Q
Int J Pharm; 2013 Mar; 446(1-2):130-5. PubMed ID: 23402975
[TBL] [Abstract][Full Text] [Related]
16. Transport of thalidomide by the human intestinal caco-2 monolayers.
Zhou S; Li Y; Kestell P; Schafer P; Chan E; Paxton JW
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):49-61. PubMed ID: 16010862
[TBL] [Abstract][Full Text] [Related]
17. Transport and uptake characteristics of a new derivative of berberine (CPU-86017) by human intestinal epithelial cell line: Caco-2.
Yang HT; Wang GJ
Acta Pharmacol Sin; 2003 Dec; 24(12):1185-91. PubMed ID: 14653942
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement.
Ma TY; Tran D; Hoa N; Nguyen D; Merryfield M; Tarnawski A
Microsc Res Tech; 2000 Oct; 51(2):156-68. PubMed ID: 11054866
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells.
Hossain Z; Kurihara H; Hosokawa M; Takahashi K
Mol Cell Biochem; 2006 Apr; 285(1-2):155-63. PubMed ID: 16477371
[TBL] [Abstract][Full Text] [Related]
20. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
Musch MW; Walsh-Reitz MM; Chang EB
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]